Vaccine for human papillomavirus (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)
Vaccine for human papillomavirus (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)
Class : A
Show all info
Contact us
Gardasil/Silgard/Cervarix. EPAR - Scientific discussion. European Medicines Agency (EMA). 2006/2007.
Giuliano AR, Isaacs-Soriano K, Torres BN, Abrahamsen M, Ingles DJ, Sirak BA et al. Immunogenicity and safety of Gardasil among mid-adult aged men (27-45 years)--The MAM Study. Vaccine. 2015;33:5640-5646.
Gardasil 9 (human papillomavirus vaccine, types 6, 11, 16, 18, 31,33, 45, 52, 58). Summary of Product Characteristics. European Medicines Agency (EMA); 2017.
Public Health Agency of Sweden. Human papilloma virus vaccination of boys in the Swedish national vaccination programme. 2017
- Gardasil/Silgard/Cervarix. EPAR - Scientific discussion. European Medicines Agency (EMA). 2006/2007.
- Giuliano AR, Isaacs-Soriano K, Torres BN, Abrahamsen M, Ingles DJ, Sirak BA et al. Immunogenicity and safety of Gardasil among mid-adult aged men (27-45 years)--The MAM Study. Vaccine. 2015;33:5640-5646.
- Gardasil 9 (human papillomavirus vaccine, types 6, 11, 16, 18, 31,33, 45, 52, 58). Summary of Product Characteristics. European Medicines Agency (EMA); 2017.
- Public Health Agency of Sweden. Human papilloma virus vaccination of boys in the Swedish national vaccination programme. 2017